.png)
Small MedTech
Reimbursement, Medical Affairs, Clinical, Marketing
Launched
Central Nervous System Disorders
Subscribe to our newsletter to receive the latest case studies.
Small MedTech
Reimbursement, Medical Affairs, Clinical, Marketing
Launched
Central Nervous System Disorders
A small medtech company had launched a new non-pharmacological treatment for patients with treatment-resistant depression.
While clinical promise was strong, establishing medical necessity and securing payer coverage required a clear articulation of burden, unmet need, and economic impact.
The client engaged Alkemi to define a payer-relevant value story and develop tools to support U.S. coverage discussions.
1. Conducted targeted literature review to assess disease burden, current treatment outcomes, and areas of unmet need.
2. Facilitated a cross-functional workshop to prioritize payer-relevant value messages across clinical, economic, and humanistic domains.
3. Developed a budget impact model to quantify economic implications and validated assumptions with thought leaders.
4. Created a payer-facing value deck to communicate burden, unmet need, and economic impact.
Clarify what matters most to payers and demonstrate impact with credible data.
"This work helped us get clear on what really mattered to payers and how to talk about it." - Marketing Leader
Aligned internal teams on the value drivers most relevant to U.S. payers.
Validated budget impact model strengthened discussions with coverage decision-makers.
The value deck and economic model were used in CMS discussions that resulted in national outpatient coverage.